The manufacturer received information alleging a cpap device's sound abatement foam became degraded and caused the patient to experience chronic lymphocytic leukemia, enlarged lymph node and fatigue.The patient did receive medical intervention in the form of diagnostic testing, chemotherapy and hospitalization.This issue was reported to the fda per 21 cfr 806.The device will be corrected per res 88058.
|
The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap and mechanical ventilator devices.The manufacturer previously received information alleging a cpap device's sound abatement foam became degraded and caused the patient to experience chronic lymphocytic leukemia, enlarged lymph node and fatigue.The patient did receive medical intervention in the form of diagnostic testing, chemotherapy and hospitalization.This notification and its severity was reviewed by the pms clinical expert due to the patient reporting enlarged lymph nodes on a chest, abdomen and pelvis ct scan, which were subsequently diagnosed as chronic lymphocytic leukemia (cll) and confirmed via lab testing.The patient also reports that the chest ct showed ground glass opacities (appearance) believed to be due to use of their device.The patient reports they stopped use of the device temporarily but returned to use due to recurrent symptoms of their underlying untreated sleep apnea while not using the device.This event is assessed as not related to the device in this case, and therefore is not a reportable injury.This event is assessed as not related to the device in this case.Based on the available information, the manufacture concludes no further action is necessary.There was no medical intervention required by the patient.Repeated attempts to have the device and components returned for evaluation and investigation were unsuccessful.The manufacturer believes they will be unable to gather additional information.The manufacturer is submitting an updated report at this time.If pertinent information becomes available to the manufacturer at a later date, a follow-up report will be filed.Section h6 updated in this report.
|